Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetMod-T1D
NCT07699380Phase 2Recruiting
- Sponsor
- University of Washington
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Countries
- 2
01
Overview
A Phase 2 trial of sodium phenylbutyrate in type 1 diabetes mellitus (T1D), sponsored by University of Washington. Started Sep 2026; status: recruiting.
02
Drugs
sodium phenylbutyrate
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07699380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07699380.